Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection
- PMID: 15560055
- DOI: 10.1016/s1089-3261(05)70318-4
Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection
Abstract
Multiple factors may influence the host-virus interaction in patients infected with hepatitis C virus (HCV), and these may result in diverse disease presentations. In immune competent hosts, there is little evidence that direct cytopathicity plays a significant role in liver cell injury. However, when host conditions are altered to allow for unusually high levels of viral replication and viral protein expression (i.e., immunosuppression), HCV may induce direct hepatocellular damage. In most patients infected with HCV, a wide array of humoral and cell-mediated immune responses are triggered in response to HCV polypeptides; however, despite this host immune response, HCV infections usually persist. Furthermore, the host immune response, in its attempt to clear the virus from the liver, contributes to the hepatocellular damage (chronic hepatitis) seen in the majority of chronically infected patients.
Similar articles
-
Pathogenesis of chronic hepatitis C virus infection.Antivir Ther. 1998;3(Suppl 3):25-35. Antivir Ther. 1998. PMID: 10726053 Review.
-
Adaptive immune responses in acute and chronic hepatitis C virus infection.Nature. 2005 Aug 18;436(7053):946-52. doi: 10.1038/nature04079. Nature. 2005. PMID: 16107834 Review.
-
Interaction between the hepatitis C virus and the immune system.Semin Liver Dis. 2000;20(2):127-41. doi: 10.1055/s-2000-9946. Semin Liver Dis. 2000. PMID: 10946419 Review.
-
The immunopathogenesis of hepatitis C virus infection.Clin Liver Dis. 2001 Nov;5(4):931-53. doi: 10.1016/s1089-3261(05)70202-6. Clin Liver Dis. 2001. PMID: 11685802 Review.
-
Hepatitis C virus infection: virus/host interactions.J Viral Hepat. 1998 Sep;5 Suppl 1:3-8. doi: 10.1046/j.1365-2893.1998.0050s1003.x. J Viral Hepat. 1998. PMID: 9795922 Review.
Cited by
-
Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.BMC Infect Dis. 2012 Apr 25;12:102. doi: 10.1186/1471-2334-12-102. BMC Infect Dis. 2012. PMID: 22533731 Free PMC article.
-
Characterization of Anti-HCV Antibodies in IL-10-Treated Patients.Viral Immunol. 2010 Aug;23(4):359-68. doi: 10.1089/vim.2009.0095. Viral Immunol. 2010. PMID: 20712480 Free PMC article.
-
The anti-idiotypic antibody 1F7 stimulates monocyte interleukin-10 production and induces endotoxin tolerance.J Inflamm (Lond). 2013 Apr 5;10(1):14. doi: 10.1186/1476-9255-10-14. J Inflamm (Lond). 2013. PMID: 23561395 Free PMC article.
-
HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma.PLoS One. 2014 Jul 31;9(7):e103748. doi: 10.1371/journal.pone.0103748. eCollection 2014. PLoS One. 2014. PMID: 25079603 Free PMC article.
-
IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection.Genes Immun. 2016 Sep;17(6):328-34. doi: 10.1038/gene.2016.27. Epub 2016 Jun 16. Genes Immun. 2016. PMID: 27307212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources